下一代腺病毒载体为基础的疫苗治疗严重急性呼吸系统综合征 冠状病毒-2
Muralimanohara S T Murala1, Vivek Gairola1, Ekramy E Sayedahmed1
1Department of Comparative Pathobiology, Purdue Institute of Inflammation, Immunology and Infectious Disease, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907-2027, USA.
这篇评论检查了腺病毒 (Ad) 生物学和广告载体COVID-19疫苗,详细介绍了免疫力和副作用等挑战. 它探讨了下一代疫苗的创新策略,提供针对SARS-CoV-2变种的广泛保护.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
背景情况:
- 腺病毒 (Ad) 载体在疫苗开发中得到了利用,特别是针对COVID-19的疫苗.
- 了解Ad生物和载体特征对于疫苗疗效至关重要.
- 现有的Ad vector疫苗面临挑战,包括先前存在的免疫力和潜在的副作用.
研究的目的:
- 系统地审查腺病毒生物学,载体结构和免疫反应.
- 分析与当前的广告载体COVID-19疫苗相关的挑战.
- 探索下一代针对SARS-CoV-2变种的广告载体疫苗的创新策略.
主要方法:
- 对腺病毒生物学进行系统性文献综述.
- 对Ad Vector疫苗结构和性能的分析.
- 对Ad Vector疫苗的免疫反应的评估.
- 探索用于改善疫苗的新战略.
主要成果:
- 腺病毒生物学和载体设计影响疫苗的有效性.
- 预先存在的免疫力和副作用对Ad Vector疫苗构成重大挑战.
- 正在制定创新策略,以提高广告载体疫苗的性能.
结论:
- 完善Ad疫苗平台对于持久免疫力至关重要.
- 下一代广告载体疫苗旨在广泛保护新出现的SARS-CoV-2变种.
- 全球准备依赖于Ad疫苗技术的进步.
更多相关视频
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
相关概念视频
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Diphtheria
Chronic Obstructive Pulmonary Disease II: Emphysema
